Sandbox:Sonya: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 19: | Line 19: | ||
*'''Diarrhea''' occurred in 85% of patients receiving drug X | *'''Diarrhea''' occurred in 85% of patients receiving drug X | ||
=====Fatigue===== | =====Fatigue===== | ||
*''Fatigue'' occurred in 90% of adult patients within 2-5 hours of receiving drug X | *'''Fatigue''' occurred in 90% of ''adult patients'' within 2-5 hours of receiving drug X | ||
=====Blurred Vision===== | =====Blurred Vision===== | ||
*Blurred vision occurred in 73% of patients receiving drug X | *'''Blurred vision''' occurred in 73% of patients receiving drug X | ||
==Brand Names== | ==Brand Names== | ||
Revision as of 19:21, 10 July 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sonya Gelfand
Overview
Dosage and Indications
Dosage
- Twice daily
- Per oral
- May be give in IV form
Indication
Warnings
Diarrhea
- Diarrhea occurred in 85% of patients receiving drug X
Fatigue
- Fatigue occurred in 90% of adult patients within 2-5 hours of receiving drug X
Blurred Vision
- Blurred vision occurred in 73% of patients receiving drug X
Brand Names
- Brand name Y
- Available in the US
- Available in Canada
- Available in the UK
- Brand name Z